To successfully develop drugs, we need to precisely predict candidate drug metabolization, efficacy, and safety before clinical trials. FluoSphera integrates these three aspects with a systemic approach to better predict the effects of drugs before they reach the patient, thus reducing drug development failure. FluoSphera provides a more predictive alternative to animal experimentation using only human-derived tissues.